UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

European journal of cancer (1990), 2012-07, Vol.48 (11), p.1649-1656

2012

Volltextzugriff (PDF)

Management of Borderline Ovarian Neoplasms

Journal of clinical oncology, 2007-07, Vol.25 (20), p.2928-2937

2007

Volltextzugriff (PDF)

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Cancer science, 2012-07, Vol.103 (7), p.1334-1341

2012

Volltextzugriff (PDF)

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

Proteome science, 2012-06, Vol.10 (1), p.41-41

2012

Volltextzugriff (PDF)

The diagnostic problem of endometrial stromal sarcoma: report on six cases

Gynecologic oncology, 2003-07, Vol.90 (1), p.37-43

2003

Volltextzugriff (PDF)

The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles

Anticancer research, 2009-04, Vol.29 (4), p.1039-1045

2009

Volltextzugriff (PDF)

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

The New England journal of medicine, 2024-02, Vol.390 (9), p.819-829

2024

Volltextzugriff (PDF)

Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data

International journal of gynecological cancer, 2012-03, Vol.22 (3), p.380-385

2012

Volltextzugriff (PDF)

The utility of proteomics in gynecologic cancers

Current opinion in obstetrics & gynecology, 2011-02, Vol.23 (1), p.3-7

2011

Volltextzugriff (PDF)

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

European journal of cancer (1990), 2012-06, Vol.48 (9), p.1332-1340

2012

Volltextzugriff (PDF)

Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD

International journal of gynecological cancer, 2013-02, Vol.23 (2), p.268-275

2013

Volltextzugriff (PDF)

Chemotherapy for recurrent cervical cancer

Gynecologic oncology, 2007-10, Vol.107 (1), p.S113-S118

2007

Volltextzugriff (PDF)

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

Gynecologic oncology, 2005-08, Vol.98 (2), p.274-280

2005

Volltextzugriff (PDF)

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients

Acta obstetricia et gynecologica Scandinavica, 2008-01, Vol.87 (7), p.783-787

2008

Volltextzugriff (PDF)

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients

European journal of cancer (1990), 2011-01, Vol.47 (2), p.191-198

2011

Volltextzugriff (PDF)

The “Leuven” paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study

Gynecologic oncology, 2013-01, Vol.128 (1), p.34-37

2013

Volltextzugriff (PDF)

Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer—a study by the OVCAD consortium

Gynecologic oncology, 2013-01, Vol.128 (1), p.38-43

2013

Volltextzugriff (PDF)

The “Leuven” dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer

Gynecologic oncology, 2007-08, Vol.106 (2), p.354-361

2007

Volltextzugriff (PDF)

Application of proteomics in ovarian cancer: Which sample should be used?

Gynecologic oncology, 2009-12, Vol.115 (3), p.497-503

2009

Volltextzugriff (PDF)

Intraperitoneal Chemotherapy in Patients with Advanced Ovarian Cancer: The Con View

The oncologist (Dayton, Ohio), 2008-04, Vol.13 (4), p.410-414

2008

Volltextzugriff (PDF)

The management of borderline tumours of the ovary

Current opinion in oncology, 2006-09, Vol.18 (5), p.488-493

2006

Volltextzugriff (PDF)

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Gynecologic oncology, 2010-07, Vol.118 (1), p.64-68

2010

Volltextzugriff (PDF)

Interval versus primary tumor debulking surgery in advanced ovarian cancer: Analysis of the European OVCAD data

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.5071-5071

2012

Volltextzugriff (PDF)

Use of HE4 and CA125 to predict surgical outcome and for prognostic value for progression-free survival (PFS) and overall survival (OS) in primary epithelial ovarian cancer (EOC) patients (pts)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.5034-5034

2012

Volltextzugriff (PDF)

Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4723-4723

2011

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

PublikationsformBuchkapitel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Female
(26)
Humans
(26)
Oncology
(24)
Obstetrics & Gynecology
(16)
Middle Aged
(15)
Adult
(14)
Aged
(11)
Hematology, Oncology And Palliative Medicine
(11)
Ovarian Neoplasms - Pathology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prognosis
(10)
Tumors
(10)
Ovarian Cancer
(9)
Chemotherapy
(8)
Ovarian Neoplasms - Drug Therapy
(8)
Aged, 80 And Over
(7)
Neoplasm Staging
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

Management of Borderline Ovarian Neoplasms

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

The diagnostic problem of endometrial stromal sarcoma: report on six cases

The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data

The utility of proteomics in gynecologic cancers

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD

Chemotherapy for recurrent cervical cancer

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients

The “Leuven” paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study

Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer—a study by the OVCAD consortium

The “Leuven” dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer

Application of proteomics in ovarian cancer: Which sample should be used?

Intraperitoneal Chemotherapy in Patients with Advanced Ovarian Cancer: The Con View

The management of borderline tumours of the ovary

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Interval versus primary tumor debulking surgery in advanced ovarian cancer: Analysis of the European OVCAD data

Use of HE4 and CA125 to predict surgical outcome and for prognostic value for progression-free survival (PFS) and overall survival (OS) in primary epithelial ovarian cancer (EOC) patients (pts)

Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

Aktive Filter

Suchergebnisse filtern